한글목차

qPCR 및 dPCR 장비 세계 시장은 2030년까지 135억 달러에 이를 전망

2023년에 75억 달러로 추정되는 qPCR 및 dPCR 장비 세계 시장은 2023-2030년간 CAGR 8.7%로 성장하여 2030년에는 135억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 qPCR 및 dPCR 시약 및 소모품은 CAGR 9.6%를 나타내고, 분석 기간 종료시에는 73억 달러에 이를 것으로 예측됩니다. qPCR 및 dPCR 기기 부문의 성장률은 분석 기간중 CAGR 7.4%로 추정됩니다.

미국 시장은 23억 달러로 추정, 중국은 CAGR 11.4%로 성장 예측

미국의 qPCR 및 dPCR 장비 시장은 2023년에 23억 달러로 추정됩니다. 세계 2위 경제대국인 중국은 2030년까지 12억 달러 규모에 이를 것으로 예측되며, 분석 기간인 2023-2030년간 CAGR은 11.4%를 나타낼 전망입니다. 기타 주목해야 할 지역별 시장으로서는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 7.2%와 7.5%를 나타낼 것으로 예측됩니다. 유럽에서는 독일이 CAGR 8.0%를 나타낼 전망입니다.

세계의 qPCR 및 dPCR 장비 시장-주요 동향과 촉진요인 정리

정량적 PCR(qPCR) 및 디지털 PCR(dPCR) 장비는 분자생물학에서 중요 툴이며, 다양한 용도에서 핵산 정확하고 정밀한 정량을 가능하게 합니다. 실시간 PCR로서도 알려진 qPCR는 PCR 프로세스중 DNA 축적을 실시간으로 측정해, 특정 DNA 배열 정량을 가능하게 합니다. 한편, dPCR는 샘플을 몇천의 개개 반응에 분할해, 표준 곡선을 필요로 하지 않고 DNA 절대정량을 실시합니다. 이 방법은 저존재량 타겟 탐지나 복잡한 혼합물 분석에 특히 유리하고, 임상 진단, 유전자 연구, 환경 검사에서 매우 유용합니다.

기술 진보에 의해 qPCR 및 dPCR 장비 성능과 능력은 대폭 향상하고 있습니다. 최신 qPCR 시스템에는 첨단서멀 사이 곳간-, 고감도 광학 탐지 시스템, 데이터 분석을 합리화하는 사용 싼 소프트웨어가 탑재되고 있습니다. 이러한 장비는 하이스루풋(High throughput)를 목표로 해 설계되고 있기 때문에 복수 샘플 동시 분석이 가능하고, 실험에 필요한 시간이 단축됩니다. 또한 multiplexing 기능 개발에 의해 1회반응으로 복수 타겟을 탐지 할 수 있게 되어, qPCR 어세이 효율과 비용 효율이 향상하고 있습니다. dPCR 기술도 진화하고 있어, 마이크로플루이딕스 플랫폼이나 액적 기반 시스템등의 기술 혁신에 의해 파티쇼닝 정도와 재현성이 향상하고 있습니다. 이러한 진보에 의해 dPCR 응용범위는 확대해, 희소인 돌연변이, 카피수 변동, 병원체 부하등을 보다 정확하게 정량 할 수 있게 되었습니다.

qPCR 및 dPCR 장비 시장 성장은 몇개의 요인에 의해 초래됩니다. 헬스케어 분야 정확하고 신속한 진단 툴에 대한 수요 증가는 특히 COVID-19 팬데믹을 받고, 신뢰성 높은 핵산 검사 필요성이 부각되었던 것이 주요 요인입니다. 유전자 발현 분석, 변이 탐지, 바이오마커 탐색에는 qPCR와 dPCR가 필수적이기 위해, 유전자 조사와 맞춤형 의료 증가도 시장 성장을 지지하고 있습니다. 보다 고감도로 하이스루풋(High throughput)장비 개발 등, 기술 진보는 분석 능력 향상을 요구하는 연구자나 임상의를 끌어당기고 있습니다. 또한 농업, 식품 안전, 환경 모니터링에의 응용 확대가, 이러한 기술 채택을 지지하고 있습니다. 유전체 연구나 공중위생에의 대처에 대한 정부 자금 원조나 투자는 시장 성장을 한층 더 지지하고 있습니다. 이러한 요인은 지속적기술 혁신과 자동화 및 디지털 솔루션 통합과 함께, qPCR 및 dPCR 장비 시장 향후 몇 년간 지속적 성장을 가속할 것으로 예상됩니다.

조사 대상 기업 예(주요 74개사)

• Abbott Laboratories, Inc.
• Agilent Technologies, Inc.
• Becton, Dickinson and Company
• Beckman Coulter, Inc.
• Bio-Rad Laboratories, Inc.
• bioMerieux SA
• Asuragen, Inc.
• Analytik Jena AG
• Biocartis NV
• Biotecon Diagnostics GmbH
• BioFire Diagnostics LLC
• Alifax SpA
• Anitoa Systems LLC
• AB ANALITICA s.r.l.
• Bio Molecular Systems

목차

제1장 조사 방법

제2장 주요 요약

• 시장 개요
• 주요 기업
• 시장 동향과 촉진요인
• 세계 시장 전망

제3장 시장 분석

• 미국
• 캐나다
• 일본
• 중국
• 유럽
• 프랑스
• 독일
• 이탈리아
• 영국
• 스페인
• 러시아
• 기타 유럽
• 아시아태평양
• 호주
• 인도
• 한국
• 기타 아시아태평양
• 라틴아메리카
• 아르헨티나
• 브라질
• 멕시코
• 기타 라틴아메리카
• 중동
• 이란
• 이스라엘
• 사우디아라비아
• 아랍에미리트(UAE)
• 기타 중동
• 아프리카

제4장 경쟁

영문목차

Global qPCR and dPCR Instrumentation Market to Reach US$13.5 Billion by 2030

The global market for qPCR and dPCR Instrumentation estimated at US$7.5 Billion in the year 2023, is expected to reach US$13.5 Billion by 2030, growing at a CAGR of 8.7% over the analysis period 2023-2030. qPCR and dPCR Reagents & Consumables, one of the segments analyzed in the report, is expected to record a 9.6% CAGR and reach US$7.3 Billion by the end of the analysis period. Growth in the qPCR and dPCR Instruments segment is estimated at 7.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.3 Billion While China is Forecast to Grow at 11.4% CAGR

The qPCR and dPCR Instrumentation market in the U.S. is estimated at US$2.3 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2030 trailing a CAGR of 11.4% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.2% and 7.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.0% CAGR.

Global qPCR and dPCR Instrumentation Market - Key Trends & Drivers Summarized

Quantitative PCR (qPCR) and digital PCR (dPCR) instrumentation are critical tools in molecular biology, enabling precise and accurate quantification of nucleic acids in various applications. qPCR, also known as real-time PCR, measures the accumulation of DNA during the PCR process in real-time, allowing for the quantification of specific DNA sequences. This technique is widely used in diagnostics, gene expression analysis, and pathogen detection due to its sensitivity, specificity, and ability to provide quantitative data. dPCR, on the other hand, partitions a sample into thousands of individual reactions, providing absolute quantification of DNA without the need for standard curves. This method is particularly advantageous for detecting low-abundance targets and analyzing complex mixtures, making it highly valuable in clinical diagnostics, genetic research, and environmental testing.

Technological advancements have significantly enhanced the performance and capabilities of qPCR and dPCR instruments. Modern qPCR systems feature advanced thermal cyclers, highly sensitive optical detection systems, and user-friendly software that streamline data analysis. These instruments are designed for high throughput, enabling simultaneous analysis of multiple samples and reducing the time required for experiments. Additionally, the development of multiplexing capabilities allows for the detection of several targets in a single reaction, increasing the efficiency and cost-effectiveness of qPCR assays. dPCR technology has also evolved, with innovations such as microfluidic platforms and droplet-based systems that enhance partitioning accuracy and reproducibility. These advancements have expanded the applications of dPCR, enabling more precise quantification of rare mutations, copy number variations, and pathogen loads.

The growth in the qPCR and dPCR instrumentation market is driven by several factors. The increasing demand for accurate and rapid diagnostic tools in the healthcare sector is a primary driver, particularly in the wake of the COVID-19 pandemic, which underscored the need for reliable nucleic acid testing. The rise in genetic research and personalized medicine is also propelling market growth, as qPCR and dPCR are essential for gene expression analysis, mutation detection, and biomarker discovery. Technological advancements, including the development of more sensitive and high-throughput instruments, are attracting researchers and clinicians seeking to improve their analytical capabilities. Furthermore, the expansion of applications in agriculture, food safety, and environmental monitoring is boosting the adoption of these technologies. Government funding and investments in genomic research and public health initiatives are further supporting market growth. These factors, combined with continuous innovation and the integration of automated and digital solutions, are expected to drive sustained growth in the qPCR and dPCR instrumentation market in the coming years.

Select Competitors (Total 74 Featured) -

• Abbott Laboratories, Inc.
• Agilent Technologies, Inc.
• Becton, Dickinson and Company
• Beckman Coulter, Inc.
• Bio-Rad Laboratories, Inc.
• bioMerieux SA
• Asuragen, Inc.
• Analytik Jena AG
• Biocartis NV
• Biotecon Diagnostics GmbH
• BioFire Diagnostics LLC
• Alifax SpA
• Anitoa Systems LLC
• AB ANALITICA s.r.l.
• Bio Molecular Systems

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Polymerase Chain Reaction (PCR): An Integral Part of Gene Amplification & Quantification
  • Global Economic Update
  • qPCR and dPCR Instrumentation - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • Real-Time PCR and Digital PCR: Scope and Definition
  • Real-Time PCR or Quantitative PCR (qPCR)
  • qPCR Instrumentation
  • Disadvantages
  • Advantages of qPCR
  • End-Use Applications of qPCR
  • Digital PCR (dPCR)
  • Working Principle
  • Applications of dPCR
  • Advantages of dPCR
  • qPCR Remains the Mainstay Technology
  • Digital PCR to Experience Strong Growth
  • High Installation Cost Remains a Roadblock to Widespread Adoption of dPCR
  • Developing Countries Drive Growth Opportunities
  • Competition
  • Competitive Factors
  • Accelerated Commercialization of Products
  • Manufacturers Step-Up Online Exposure
  • Targeted Expansion of Distribution Reach and Global Footprint
  • Recent Market Activity
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Striking the Right Balance between qPCR and dPCR in Research Laboratories
  • qPCR: A Suitable Tool for Gene Expression and Validation
  • Digital PCR Takes Quantification of Nucleic Acids to the Next Level
  • dPCR: A Valuable Tool in Virology Research
  • Increasing Incidence and Prevalence of Cancer: A Grim Reality Driving Demand for qPCR and dPCR
  • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
  • dPCR for Analyzing Hematologic Malignancies
  • dPCR for Liquid Biopsies
  • Progress in Molecular Diagnostics Spur Demand for the Gene Amplification Technologies
  • Prospects for Predictive Genetic Diagnostics and Testing Grow Brighter
  • Global Genetic Testing Market in US$ Billion: 2020 and 2027
  • Rise in Infectious Diseases Drives Opportunities for Biochips
  • Infectious Diseases Remain Major Cause of Death in Under Developed Regions: Breakdown of Leading Causes of Death in Sub-Saharan Africa (in %)
  • Infectious Diseases Related Mortality High Among Children Below 5 Years: Breakdown of Leading Causes of Death in Children Below 5 Years (in %)
  • Innovations in Instrumentation Expand Functionality and Drive Adoption
  • Advancements in Probe Technology Enhance qPCR Sensitivity
  • qPCR Market to Witness Increasing Affinity for Automated and Robotic Equipment
  • Lab on Chip/Microfluidic Real-time-PCR
  • Synoptic Review of Quantitative PCR Technical Advancements in the Recent Years
  • ddPCR: The More Advanced Digital Approach to dPCR
  • ddPCR Gains Traction in Cancer Diagnosis
  • Monitoring Disease Progression in HIV Studies
  • Analysis of Genetically Modified Organisms in Edible Products
  • RT-ddPCR Techniques Applied for Quantitating RNA Viruses in Water Samples
  • Technology Advancements Aid in Overcoming Barriers
  • Alternate Technologies Pose Threat to Growth of PCR Market
  • Improving Healthcare Expenditure to Drive Demand for qPCR and dPCR-based Tests
  • World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
  • PCR in Forensic and Paternity Testing
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for qPCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 2: World Historic Review for qPCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 3: World 16-Year Perspective for qPCR by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for dPCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 5: World Historic Review for dPCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 6: World 16-Year Perspective for dPCR by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 7: World Recent Past, Current & Future Analysis for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 8: World Historic Review for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 9: World 16-Year Perspective for Reagents & Consumables by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 11: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 12: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 13: World Recent Past, Current & Future Analysis for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 14: World Historic Review for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 15: World 16-Year Perspective for Software & Services by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 16: World Recent Past, Current & Future Analysis for Hospitals & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 17: World Historic Review for Hospitals & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 18: World 16-Year Perspective for Hospitals & Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 19: World Recent Past, Current & Future Analysis for Research Laboratories & Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 20: World Historic Review for Research Laboratories & Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 21: World 16-Year Perspective for Research Laboratories & Academic Institutes by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 22: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 23: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 24: World 16-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 25: World Recent Past, Current & Future Analysis for Clinical Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 26: World Historic Review for Clinical Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 27: World 16-Year Perspective for Clinical Research Organizations by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 28: World Recent Past, Current & Future Analysis for Forensic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 29: World Historic Review for Forensic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 30: World 16-Year Perspective for Forensic Laboratories by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 31: World qPCR and dPCR Instrumentation Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 33: World Historic Review for qPCR and dPCR Instrumentation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 34: World 16-Year Perspective for qPCR and dPCR Instrumentation by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • qPCR and dPCR Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • TABLE 35: USA Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 37: USA 16-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2014, 2024 & 2030
  • TABLE 38: USA Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 40: USA 16-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • TABLE 41: USA Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 43: USA 16-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2014, 2024 & 2030
• CANADA
  • TABLE 44: Canada Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 46: Canada 16-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2014, 2024 & 2030
  • TABLE 47: Canada Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 49: Canada 16-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • TABLE 50: Canada Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 52: Canada 16-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2014, 2024 & 2030
• JAPAN
  • qPCR and dPCR Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • TABLE 53: Japan Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 55: Japan 16-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2014, 2024 & 2030
  • TABLE 56: Japan Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 58: Japan 16-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • TABLE 59: Japan Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 61: Japan 16-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2014, 2024 & 2030
• CHINA
  • qPCR and dPCR Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • TABLE 62: China Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 63: China Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 64: China 16-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2014, 2024 & 2030
  • TABLE 65: China Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 66: China Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 67: China 16-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • TABLE 68: China Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 69: China Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 70: China 16-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2014, 2024 & 2030
• EUROPE
  • qPCR and dPCR Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • TABLE 71: Europe Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 73: Europe 16-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2014, 2024 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 76: Europe 16-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 79: Europe 16-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2014, 2024 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for qPCR and dPCR Instrumentation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 82: Europe 16-Year Perspective for qPCR and dPCR Instrumentation by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
• FRANCE
  • qPCR and dPCR Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • TABLE 83: France Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 84: France Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 85: France 16-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2014, 2024 & 2030
  • TABLE 86: France Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 87: France Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 88: France 16-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • TABLE 89: France Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 90: France Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 91: France 16-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2014, 2024 & 2030
• GERMANY
  • qPCR and dPCR Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • TABLE 92: Germany Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 94: Germany 16-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2014, 2024 & 2030
  • TABLE 95: Germany Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 97: Germany 16-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • TABLE 98: Germany Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 100: Germany 16-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2014, 2024 & 2030
• ITALY
  • TABLE 101: Italy Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 103: Italy 16-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2014, 2024 & 2030
  • TABLE 104: Italy Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 106: Italy 16-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • TABLE 107: Italy Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 109: Italy 16-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2014, 2024 & 2030
• UNITED KINGDOM
  • qPCR and dPCR Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • TABLE 110: UK Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 112: UK 16-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2014, 2024 & 2030
  • TABLE 113: UK Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 115: UK 16-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • TABLE 116: UK Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 118: UK 16-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2014, 2024 & 2030
• SPAIN
  • TABLE 119: Spain Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 120: Spain Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 121: Spain 16-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2014, 2024 & 2030
  • TABLE 122: Spain Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 124: Spain 16-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • TABLE 125: Spain Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 127: Spain 16-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2014, 2024 & 2030
• RUSSIA
  • TABLE 128: Russia Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 129: Russia Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 130: Russia 16-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2014, 2024 & 2030
  • TABLE 131: Russia Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 133: Russia 16-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • TABLE 134: Russia Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 136: Russia 16-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2014, 2024 & 2030
• REST OF EUROPE
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 139: Rest of Europe 16-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2014, 2024 & 2030
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 142: Rest of Europe 16-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 145: Rest of Europe 16-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2014, 2024 & 2030
• ASIA-PACIFIC
  • qPCR and dPCR Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 148: Asia-Pacific 16-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2014, 2024 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 151: Asia-Pacific 16-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 154: Asia-Pacific 16-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2014, 2024 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for qPCR and dPCR Instrumentation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 157: Asia-Pacific 16-Year Perspective for qPCR and dPCR Instrumentation by Geographic Region - Percentage Breakdown of Value Revenues for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
• AUSTRALIA
  • qPCR and dPCR Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
  • TABLE 158: Australia Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 160: Australia 16-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2014, 2024 & 2030
  • TABLE 161: Australia Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 163: Australia 16-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • TABLE 164: Australia Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 166: Australia 16-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2014, 2024 & 2030
• INDIA
  • qPCR and dPCR Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
  • TABLE 167: India Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 168: India Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 169: India 16-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2014, 2024 & 2030
  • TABLE 170: India Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 171: India Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 172: India 16-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • TABLE 173: India Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 174: India Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 175: India 16-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2014, 2024 & 2030
• SOUTH KOREA
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 177: South Korea Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 178: South Korea 16-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2014, 2024 & 2030
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 181: South Korea 16-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 184: South Korea 16-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2014, 2024 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2014, 2024 & 2030
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 16-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 16-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2014, 2024 & 2030
• LATIN AMERICA
  • qPCR and dPCR Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 196: Latin America 16-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2014, 2024 & 2030
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 199: Latin America 16-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 202: Latin America 16-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2014, 2024 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for qPCR and dPCR Instrumentation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 205: Latin America 16-Year Perspective for qPCR and dPCR Instrumentation by Geographic Region - Percentage Breakdown of Value Revenues for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
• ARGENTINA
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 207: Argentina Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 208: Argentina 16-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2014, 2024 & 2030
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 211: Argentina 16-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 214: Argentina 16-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2014, 2024 & 2030
• BRAZIL
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 216: Brazil Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 217: Brazil 16-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2014, 2024 & 2030
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 220: Brazil 16-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 223: Brazil 16-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2014, 2024 & 2030
• MEXICO
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 225: Mexico Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 226: Mexico 16-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2014, 2024 & 2030
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 229: Mexico 16-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 232: Mexico 16-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2014, 2024 & 2030
• REST OF LATIN AMERICA
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 235: Rest of Latin America 16-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2014, 2024 & 2030
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 238: Rest of Latin America 16-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 241: Rest of Latin America 16-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2014, 2024 & 2030
• MIDDLE EAST
  • qPCR and dPCR Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 244: Middle East 16-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2014, 2024 & 2030
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 247: Middle East 16-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 250: Middle East 16-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2014, 2024 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for qPCR and dPCR Instrumentation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 253: Middle East 16-Year Perspective for qPCR and dPCR Instrumentation by Geographic Region - Percentage Breakdown of Value Revenues for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
• IRAN
  • TABLE 254: Iran Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 255: Iran Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 256: Iran 16-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2014, 2024 & 2030
  • TABLE 257: Iran Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 259: Iran 16-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • TABLE 260: Iran Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 262: Iran 16-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2014, 2024 & 2030
• ISRAEL
  • TABLE 263: Israel Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 264: Israel Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 265: Israel 16-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2014, 2024 & 2030
  • TABLE 266: Israel Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 268: Israel 16-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • TABLE 269: Israel Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 271: Israel 16-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2014, 2024 & 2030
• SAUDI ARABIA
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 274: Saudi Arabia 16-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2014, 2024 & 2030
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 277: Saudi Arabia 16-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 280: Saudi Arabia 16-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2014, 2024 & 2030
• UNITED ARAB EMIRATES
  • TABLE 281: UAE Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 282: UAE Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 283: UAE 16-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2014, 2024 & 2030
  • TABLE 284: UAE Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 286: UAE 16-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • TABLE 287: UAE Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 289: UAE 16-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2014, 2024 & 2030
• REST OF MIDDLE EAST
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 292: Rest of Middle East 16-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2014, 2024 & 2030
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 295: Rest of Middle East 16-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 298: Rest of Middle East 16-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2014, 2024 & 2030
• AFRICA
  • qPCR and dPCR Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
  • TABLE 299: Africa Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 300: Africa Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 301: Africa 16-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2014, 2024 & 2030
  • TABLE 302: Africa Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 304: Africa 16-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • TABLE 305: Africa Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 307: Africa 16-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2014, 2024 & 2030

IV. COMPETITION